Skip to content
10-Q

Quarterly Report

BIOSYNERGY INC

0000715812-19-000026

← back to feed
Filed
Dec 16, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Oct 31, 2019 14.94M sh
Stockholders Equity Q2 2019 · Oct 31, 2019 $1.72M
Stockholders Equity Q2 2019 · Apr 30, 2019 $1.69M
Current Liabilities Q2 2019 · Oct 31, 2019 $92.85K
Current Liabilities Q2 2019 · Apr 30, 2019 $156.29K
Current Assets Q2 2019 · Oct 31, 2019 $1.66M
Current Assets Q2 2019 · Apr 30, 2019 $1.65M
Total Assets Q2 2019 · Oct 31, 2019 $1.84M
Total Assets Q2 2019 · Apr 30, 2019 $1.87M
Revenue Q2 2019 · Oct 31, 2019 $312.3K
Revenue Q2 2019 · Oct 31, 2019 $629.09K
Revenue Q2 2019 · Oct 31, 2018 $328.43K
Revenue Q2 2019 · Oct 31, 2018 $646.26K
Operating Cash Flow Q2 2019 · Oct 31, 2018 $40.83K
Cash And Equivalents Q2 2019 · Oct 31, 2018 $1.18M
Cash And Equivalents Q2 2019 · Apr 30, 2018 $1.14M
Sga Expense Q2 2019 · Oct 31, 2018 $97.62K
Sga Expense Q2 2019 · Oct 31, 2018 $214.96K
Rd Expense Q2 2019 · Oct 31, 2018 $38.91K
Rd Expense Q2 2019 · Oct 31, 2018 $75.83K
Net Income Q2 2019 · Oct 31, 2018 $26K
Net Income Q2 2019 · Oct 31, 2018 $36.38K
Operating Income Q2 2019 · Oct 31, 2018 $35.75K
Operating Income Q2 2019 · Oct 31, 2018 $49.7K
Gross Profit Q2 2019 · Oct 31, 2018 $220.54K
Gross Profit Q2 2019 · Oct 31, 2018 $434.46K